Infection Control Today - National Institutes Of Health (NIH)

Anadys Pharmaceuticals to Receive Up to $1.2 Million From NIH for Development of Novel Antibacterials

SAN DIEGO -- Anadys Pharmaceuticals, Inc., a biopharmaceutical company committed to the discovery, development and commercialization of novel medicines to treat chronic viral hepatitis and bacterial infections, announced that it has been awarded a Phase II Small Business ...More

September 21, 2004

Posted in News

Rhode Island Biotechnology Company Wins NIH BioDefense Award to Develop Tularemia Vaccine

PROVIDENCE, R.I. -- EpiVax, Inc, a leading provider of protein and genome analysis services, vaccine components, and vaccine candidates, has been awarded a BioDefense Phase I Small Business Innovation Research (SBIR) grant by the National Institute of Allergy and Infectious ...More

September 13, 2004

Posted in News

Diversa Awarded NIH Grant to Develop New Antibodies Targeting SARS

SAN DIEGO -- Diversa Corporation announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the company a grant for the discovery and development of antibodies to diagnose and treat Severe ...More

September 8, 2004

Posted in News, PPE & Standard Precautions

Duke University Medical Center Awarded $4 Million in First NIH Grant for AIDS Co-Infection Study

DURHAM, N.C. -- Researchers at Duke University Medical Center have received a $4 million, four-year grant from the National Institutes of Health to study infectious diseases that plague AIDS patients in Tanzania. The grant is the first and only award bestowed this year ...More

August 24, 2004

Posted in News

GenVec and NIH Move HIV Vaccine Candidate Into Human Clinical Trials

GAITHERSBURG, Md. -- GenVec, Inc. announced today that the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has initiated a Phase I clinical study to test an HIV vaccine candidate ...More

July 28, 2004

Posted in News

NIH Supports Phase 1 Clinical Trial of Vical's DNA-Based Anthrax Vaccine

SAN DIEGO -- Vical Incorporated announces that the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) has advised the company that it will support a Phase 1 clinical trial of the company's investigational plasmid ...More

June 10, 2004

Posted in News

Weekly Cycles of Once-Daily Anti-HIV Drugs Could Reduce Cost of HIV Treatment

In a small study conducted at the U.S. National Institutes of Health (NIH), researchers have shown that it may be feasible to treat HIV-infected patients with a simple, once-daily regimen of anti-HIV drugs given in pre-planned, seven-day-on, seven-day-off cycles. This ...More

May 21, 2004

Posted in News

National Vaccine Information Center Says IOM Played Politics in Report on Autism and Vaccines

WASHINGTON -- The nation's largest and oldest parent- led vaccine safety organization is charging that today's report on autism and vaccines issued by the Institute of Medicine (IOM) seriously jeopardizes the credibility of IOM to make an objective scientific analysis of ...More

May 19, 2004

Posted in News

NIAID Rotavirus Vaccine Licensed for Commercialization

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today a new license agreement aimed at helping to prevent hundreds of thousands of deaths annually from rotavirus diarrhea in children living in ...More

May 5, 2004

Posted in News

Computers Combat Disease: New Modeling Grants Target Epidemics, Bioterrorism

A new initiative will harness the nation's computing skill to enhance the ability to respond to disease epidemics and bioterrorism. The initiative, called MIDAS, will develop powerful computer modeling techniques to analyze and respond to infectious disease outbreaks, ...More

May 5, 2004

Posted in News

ANTIMICROBIAL PRODUCTS	DISINFECTION/STERILIZA...
DISPOSABLE PRODUCTS	INFECTION CONTROL
LATEX-FREE PRODUCTS	More Options...

National Institutes Of Health (NIH)

Video Snapshot

Galleries

ICT Poll

Most Popular Articles

Buyer's Guide

Reports

Free Email Updates

featured links

First Name	Last Name
E-Mail